Dalman, Teodora A.
HRN: 09-58-19 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
06/15/2023
MUPIROCIN 2%, 15G (TUBE)
06/15/2023
06/21/2023
TOPICAL
Ample Amount
BID
Infected Wound
Waiting Final Action
Indication: Empiric Type of Infection: Skin & Soft Tissue Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes